Laboratory Corporation of America Holdings Company Profile (NYSE:LH)

About Laboratory Corporation of America Holdings (NYSE:LH)

Laboratory Corporation of America Holdings logoLaboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:LH
  • CUSIP: 50540R40
  • Web: www.labcorp.com
Capitalization:
  • Market Cap: $15.65175 billion
  • Outstanding Shares: 101,800,000
Average Prices:
  • 50 Day Moving Avg: $156.24
  • 200 Day Moving Avg: $147.88
  • 52 Week Range: $119.51 - $164.22
P/E:
  • Trailing P/E Ratio: 21.41
  • Foreward P/E Ratio: 14.52
  • P/E Growth: 1.80
Sales & Book Value:
  • Annual Revenue: $9.67 billion
  • Price / Sales: 1.61
  • Book Value: $57.63 per share
  • Price / Book: 2.65
Profitability:
  • EBIDTA: $1.86 billion
  • Net Margins: 7.57%
  • Return on Equity: 16.85%
  • Return on Assets: 6.55%
Debt:
  • Debt-to-Equity Ratio: 0.95%
  • Current Ratio: 1.39%
  • Quick Ratio: 1.28%
Misc:
  • Average Volume: 666,884 shs.
  • Beta: 0.94
  • Short Ratio: 3.29
 

Frequently Asked Questions for Laboratory Corporation of America Holdings (NYSE:LH)

What is Laboratory Corporation of America Holdings' stock symbol?

Laboratory Corporation of America Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corporation of America Holdings' earnings last quarter?

Laboratory Corporation of America Holdings (NYSE:LH) issued its quarterly earnings data on Wednesday, July, 26th. The company reported $2.47 earnings per share for the quarter, beating the Zacks' consensus estimate of $2.40 by $0.07. The firm earned $2.50 billion during the quarter, compared to analyst estimates of $2.47 billion. Laboratory Corporation of America Holdings had a return on equity of 16.85% and a net margin of 7.57%. The business's quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the business posted $2.36 earnings per share. View Laboratory Corporation of America Holdings' Earnings History.

When will Laboratory Corporation of America Holdings make its next earnings announcement?

Laboratory Corporation of America Holdings is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Laboratory Corporation of America Holdings.

What guidance has Laboratory Corporation of America Holdings issued on next quarter's earnings?

Laboratory Corporation of America Holdings updated its FY17 earnings guidance on Wednesday, July, 26th. The company provided EPS guidance of $9.30-9.65 for the period, compared to the Thomson Reuters consensus estimate of $9.43. The company issued revenue guidance of +5.0-6.5% to ~9.91-10.05 billion, compared to the consensus revenue estimate of $9.86 billion.

Where is Laboratory Corporation of America Holdings' stock going? Where will Laboratory Corporation of America Holdings' stock price be in 2017?

10 analysts have issued 1-year price targets for Laboratory Corporation of America Holdings' shares. Their predictions range from $138.00 to $183.00. On average, they expect Laboratory Corporation of America Holdings' stock price to reach $165.10 in the next twelve months. View Analyst Ratings for Laboratory Corporation of America Holdings.

What are analysts saying about Laboratory Corporation of America Holdings stock?

Here are some recent quotes from research analysts about Laboratory Corporation of America Holdings stock:

  • 1. According to Zacks Investment Research, "LabCorp posted a better-than-expected quarter with second-quarter earnings and revenues, both topping the respective Zacks Consensus Estimate. While Diagnostics business was strong, Covance Drug Development provided dull numbers. As per LabCorp, the impact of the cancellation by sponsors of two large clinical studies in late 2016 affected the results. This apart, an unfavorable foreign exchange continues to hamper overall result. Yet, an increased 2017 guidance boosted investors’ confidence indicating chances of respite anytime soon. We believe that with the integration of newer acquisitions, LabCorp is perfectly positioned to drive long-term profitable growth. We note that, this overall mixed performance has been reflected in the company’s share price trend too. In majority of the last one month, LabCorp was trading below the broader industry. However, of late it has started to tread up and is currently trading above the industry." (7/27/2017)
  • 2. Canaccord Genuity analysts commented, "LH bounced back from an underwhelming Q3 with a good Q4 that beat our/consensus estimates on the top and bottom lines. The 2017 guide is what we expected and we believe sets an appropriate bar for the company to execute against. LH spent a good portion of time on its call (in the Q&A) defending its strategic planning and responded to questions about its reported interest (Reuters) to acquire NC-based CRO Pharmaceutical Product Development (PPD) for ~$8 billion. While on one hand the deal would make sense to bolster its Covance business, our sense from investors is that most would prefer to see LH return more of its capital to shareholders in the form of share repurchases, which LH re-initiated in Q4. Regardless, we think the stock is cheap and it remains one of our five top picks for 2017 as we expect "mean-reverted" multiple expansion and another solid year of FCF (~$975M, or $9.43/sh.) and strong capital deployment. BUY. We raise our estimates and PT to $150 from $140." (2/17/2017)
  • 3. Mizuho analysts commented, "We are raising our price target to $139 ($135 previously) post 4Q on betterthan-expected cash flow guidance. We are maintaining our 2017E and 2018E adjusted EPS estimates of $9.65 and $10.32, respectively. LH reported a good 4Q and initial 2017 guidance despite some noise. The company also noted a more conservative approach to its CRO metrics, which we view favorably." (2/17/2017)

Who are some of Laboratory Corporation of America Holdings' key competitors?

Who are Laboratory Corporation of America Holdings' key executives?

Laboratory Corporation of America Holdings' management team includes the folowing people:

  • David P. King, Chairman of the Board, President, Chief Executive Officer
  • Glenn A. Eisenberg, Chief Financial Officer, Executive Vice President
  • John D. Ratliff, Chief Executive Officer - Covance Drug Development
  • Lisa J. Uthgenannt, Chief Human Resource Officer
  • Edward T. Dodson, Senior Vice President, Chief Accounting Officer, Principal Accounting Officer
  • Lance V. Berberian, Senior Vice President, Chief Information Officer
  • F. Samuel Eberts III, Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer
  • Robert E. Mittelstaedt Jr., Lead Independent Director
  • Kerrii B. Anderson, Independent Director
  • Jean-Luc Belingard, Independent Director

Who owns Laboratory Corporation of America Holdings stock?

Laboratory Corporation of America Holdings' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.18%), BlackRock Inc. (7.59%), Boston Partners (4.48%), State Street Corp (4.51%), Nordea Investment Management AB (2.65%) and Glenview Capital Management LLC (2.62%). Company insiders that own Laboratory Corporation of America Holdings stock include David P King, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, James T Jr Boyle, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corporation of America Holdings.

Who sold Laboratory Corporation of America Holdings stock? Who is selling Laboratory Corporation of America Holdings stock?

Laboratory Corporation of America Holdings' stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, BlackRock Inc., Federated Investors Inc. PA, Jennison Associates LLC, Ameriprise Financial Inc., Cibc World Markets Corp, Nationwide Fund Advisors and Voya Investment Management LLC. Company insiders that have sold Laboratory Corporation of America Holdings stock in the last year include David P King, F Samuel Eberts III, Glenn A Eisenberg, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Insider Buying and Selling for Laboratory Corporation of America Holdings.

Who bought Laboratory Corporation of America Holdings stock? Who is buying Laboratory Corporation of America Holdings stock?

Laboratory Corporation of America Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Schroder Investment Management Group, UBS Asset Management Americas Inc., Empyrean Capital Partners LP, Bessemer Group Inc., HealthCor Management L.P., Renaissance Technologies LLC and Meag Munich Ergo Kapitalanlagegesellschaft MBH. View Insider Buying and Selling for Laboratory Corporation of America Holdings.

How do I buy Laboratory Corporation of America Holdings stock?

Shares of Laboratory Corporation of America Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Laboratory Corporation of America Holdings' stock price today?

One share of Laboratory Corporation of America Holdings stock can currently be purchased for approximately $152.85.


MarketBeat Community Rating for Laboratory Corporation of America Holdings (NYSE LH)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  290 (Vote Outperform)
Underperform Votes:  351 (Vote Underperform)
Total Votes:  641
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corporation of America Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Laboratory Corporation of America Holdings (NYSE:LH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Hold Ratings, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $165.10 (8.01% upside)

Analysts' Ratings History for Laboratory Corporation of America Holdings (NYSE:LH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/17/2017Robert W. BairdReiterated RatingNeutral -> HoldLowView Rating Details
9/13/2017Jefferies Group LLCReiterated RatingHold$157.00 -> $170.00MediumView Rating Details
9/11/2017Canaccord GenuityReiterated RatingBuy$175.00 -> $180.00MediumView Rating Details
8/10/2017Morgan StanleyBoost Price TargetOverweight$154.00 -> $166.00LowView Rating Details
7/27/2017Barclays PLCBoost Price TargetOverweight$182.00 -> $183.00LowView Rating Details
7/27/2017Craig HallumReiterated RatingBuy$157.00 -> $179.00MediumView Rating Details
7/13/2017Credit Suisse GroupDowngradeHold$146.00LowView Rating Details
2/17/2017MizuhoBoost Price TargetNeutral$135.00 -> $139.00N/AView Rating Details
1/18/2017Deutsche Bank AGReiterated RatingBuy$170.00N/AView Rating Details
10/25/2016GabelliInitiated CoverageBuy$180.00N/AView Rating Details
9/9/2016Citigroup Inc.Initiated CoverageNeutral$156.00N/AView Rating Details
8/16/2016KeyCorpBoost Price TargetOverweight$143.00 -> $150.00N/AView Rating Details
7/28/2016SunTrust Banks, Inc.Reiterated RatingBuyN/AView Rating Details
7/27/2016Evercore ISIBoost Price TargetBuy$147.00 -> $155.00N/AView Rating Details
3/23/2016Goldman Sachs Group, Inc. (The)Boost Price Target$119.00N/AView Rating Details
3/4/2016William BlairReiterated RatingOutperformN/AView Rating Details
2/19/2016Royal Bank Of CanadaLower Price TargetSector Perform$135.00 -> $130.00N/AView Rating Details
2/4/2016Raymond James Financial, Inc.Lower Price TargetOutperform$145.00 -> $135.00N/AView Rating Details
12/17/2015Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
(Data available from 9/20/2015 forward)

Earnings

Earnings History for Laboratory Corporation of America Holdings (NYSE:LH)
Earnings by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Earnings History by Quarter for Laboratory Corporation of America Holdings (NYSE LH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$2.44N/AView Earnings Details
7/26/2017Q2 2017$2.40$2.47$2.47 billion$2.50 billionViewN/AView Earnings Details
4/25/2017Q1 2017$2.19$2.22$2.41 billion$2.41 billionViewN/AView Earnings Details
2/16/2017Q416$2.13$2.15$2.35 billion$2.39 billionViewListenView Earnings Details
10/26/2016Q316$2.29$2.25$2.38 billion$2.40 billionViewListenView Earnings Details
7/27/2016Q216$2.30$2.31$2.33 billion$2.40 billionViewListenView Earnings Details
4/25/2016Q116$1.96$2.02$2.19 billion$2.30 billionViewListenView Earnings Details
2/18/2016Q415$1.99$1.98$2.22 billion$2.24 billionViewListenView Earnings Details
10/26/2015Q315$2.07$2.07$2.25 billion$2.30 billionViewListenView Earnings Details
7/28/2015Q215$2.03$2.09$2.22 billion$2.20 billionViewListenView Earnings Details
4/27/2015Q115$1.63$1.73$1.79 billion$1.80 billionViewListenView Earnings Details
2/20/2015Q4$1.63$1.65$1.49 billion$1.51 billionViewListenView Earnings Details
10/28/2014Q3$1.75$1.80$1.56 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$1.77$1.84$1.50 billion$1.52 billionViewN/AView Earnings Details
4/28/2014Q114$1.58$1.51$1.45 billion$1.43 billionViewListenView Earnings Details
2/7/2014Q413$1.66$1.61$1.46 billion$1.44 billionViewListenView Earnings Details
10/18/2013Q313$1.80$1.80$1.45 billion$1.46 billionViewListenView Earnings Details
7/19/2013Q2 2013$1.80$1.80$1.46 billion$1.47 billionViewListenView Earnings Details
4/19/2013Q1 2013$1.77$1.74$1.45 billion$1.44 billionViewListenView Earnings Details
2/8/2013Q4 2012$1.62$1.54$1.39 billion$1.41 billionViewListenView Earnings Details
10/18/2012$1.74$1.76ViewN/AView Earnings Details
7/19/2012$1.76$1.77ViewN/AView Earnings Details
4/19/2012$1.67$1.74ViewN/AView Earnings Details
2/10/2012$1.41$1.46ViewN/AView Earnings Details
10/20/2011$1.50$1.61ViewN/AView Earnings Details
7/21/2011$1.53$1.64ViewN/AView Earnings Details
4/21/2011$1.46$1.52ViewN/AView Earnings Details
2/10/2011$1.31$1.34ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Laboratory Corporation of America Holdings (NYSE:LH)
2017 EPS Consensus Estimate: $9.39
2018 EPS Consensus Estimate: $10.45
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.16$2.26$2.22
Q2 20175$2.41$2.50$2.46
Q3 20175$2.13$2.46$2.38
Q4 20175$2.01$2.45$2.33
Q1 20183$2.34$2.42$2.39
Q2 20183$2.63$2.75$2.70
Q3 20183$2.66$2.74$2.70
Q4 20183$2.65$2.68$2.66
Q1 20191$2.60$2.60$2.60
Q2 20191$2.99$2.99$2.99
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Laboratory Corporation of America Holdings (NYSE:LH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Laboratory Corporation of America Holdings (NYSE:LH)
Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 93.19%
Insider Trades by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Insider Trades by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2017David P KingCEOSell44,687$156.86$7,009,602.82View SEC Filing  
9/5/2017David P. KingCEOSell132,713$157.06$20,843,903.78View SEC Filing  
8/25/2017F Samuel Eberts IIIInsiderSell31,500$155.22$4,889,430.00View SEC Filing  
8/11/2017R Sanders WilliamsDirectorSell3,100$156.88$486,328.00View SEC Filing  
8/1/2017Glenn A EisenbergCFOSell5,968$159.46$951,657.28View SEC Filing  
8/1/2017Lisa J. UthgenanntInsiderSell5,000$160.00$800,000.00View SEC Filing  
5/22/2017Lance BerberianSVPSell3,613$139.84$505,241.92View SEC Filing  
5/9/2017Jean-Luc BelingardDirectorSell992$142.19$141,052.48View SEC Filing  
3/9/2017Glenn A EisenbergCFOSell2,300$142.47$327,681.00View SEC Filing  
2/24/2017Robert E Mittelstaedt JrDirectorSell5,300$142.69$756,257.00View SEC Filing  
8/9/2016Lisa J UthgenanntInsiderSell1,177$140.00$164,780.00View SEC Filing  
8/4/2016Glenn A EisenbergCFOSell8,000$140.10$1,120,800.00View SEC Filing  
8/4/2016Robert E Mittelstaedt JrDirectorSell992$140.15$139,028.80View SEC Filing  
6/13/2016David P KingCEOSell196,400$128.00$25,139,200.00View SEC Filing  
4/27/2016Edward T DodsonInsiderSell9,392$126.42$1,187,336.64View SEC Filing  
3/31/2016F Samuel Eberts IIIInsiderSell4,219$116.85$492,990.15View SEC Filing  
3/31/2016James T Jr. BoyleCEOSell18,132$116.81$2,117,998.92View SEC Filing  
3/14/2016F Samuel Eberts IIIInsiderSell309$115.32$35,633.88View SEC Filing  
3/14/2016James T Jr. BoyleCEOSell1,543$115.32$177,938.76View SEC Filing  
2/25/2016Jean-Luc BelingardDirectorSell1,296$109.74$142,223.04View SEC Filing  
2/16/2016F Samuel Eberts IIIInsiderSell370$103.02$38,117.40View SEC Filing  
2/16/2016James T. Jr. BoyleCEOSell4,055$103.02$417,746.10View SEC Filing  
2/12/2016F Samuel Eberts IIIinsiderSell405$101.67$41,176.35View SEC Filing  
2/12/2016James T. Jr. BoyleCEOSell2,712$101.67$275,729.04View SEC Filing  
1/8/2016F Samuel Eberts IIIInsiderSell1,215$119.05$144,645.75View SEC Filing  
12/8/2015F Samuel Eberts IIIInsiderSell1,010$123.31$124,543.10View SEC Filing  
11/2/2015R Sanders WilliamsDirectorSell1,850$124.30$229,955.00View SEC Filing  
7/1/2015David P KingCEOSell50,000$121.78$6,089,000.00View SEC Filing  
4/29/2015Jean-Luc BelingardDirectorSell1,542$123.10$189,820.20View SEC Filing  
4/23/2015James T Jr. BoyleCEOSell1,394$126.56$176,424.64View SEC Filing  
3/31/2015Mark E BrecherCMOSell20,625$126.98$2,618,962.50View SEC Filing  
3/30/2015Mark E BrecherCMOSell20,278$126.98$2,574,900.44View SEC Filing  
3/3/2015James T Jr. BoyleCOOSell1,237$123.70$153,016.90View SEC Filing  
2/13/2015James T Jr. BoyleCOOSell6,597$116.68$769,737.96View SEC Filing  
9/22/2014David P KingCEOSell65,234$104.71$6,830,652.14View SEC Filing  
9/5/2014R Sanders WilliamsDirectorSell2,000$107.95$215,900.00View SEC Filing  
8/22/2014David P KingCEOSell65,233$106.10$6,921,221.30View SEC Filing  
7/22/2014David P KingCEOSell65,233$105.55$6,885,343.15View SEC Filing  
6/9/2014James T Jr. BoyleCOOSell38,600$103.00$3,975,800.00View SEC Filing  
5/7/2014M Keith WeikelDirectorSell1,984$98.28$194,987.52View SEC Filing  
3/28/2014James Jr. BoyleCOOSell2,521$98.36$247,965.56View SEC Filing  
3/7/2014William HayesCFOSell23,848$94.40$2,251,251.20View SEC Filing  
2/13/2014James Jr. BoyleCOOSell4,123$90.29$372,265.67View SEC Filing  
2/11/2014James Jr. BoyleCOOSell1,204$91.15$109,744.60View SEC Filing  
1/27/2014David KingCEOSell24,200$90.15$2,181,630.00View SEC Filing  
12/24/2013David KingCEOSell25,000$90.79$2,269,750.00View SEC Filing  
10/24/2013David P KingCEOSell25,000$100.91$2,522,750.00View SEC Filing  
10/17/2013James T Jr. BoyleCOOSell24,400$102.00$2,488,800.00View SEC Filing  
9/25/2013David KingCEOSell25,000$99.06$2,476,500.00View SEC Filing  
8/26/2013David KingCEOSell25,000$96.60$2,415,000.00View SEC Filing  
8/21/2013Robert Mittelstaedt, Jr.DirectorSell7,429$96.86$719,572.94View SEC Filing  
7/24/2013David P KingCEOSell25,000$97.72$2,443,000.00View SEC Filing  
6/24/2013David P KingCEOSell25,000$98.66$2,466,500.00View SEC Filing  
6/7/2013James T Jr. BoyleCOOSell63,100$99.63$6,286,653.00View SEC Filing  
5/28/2013Mark E BrecherInsiderSell16,900$100.92$1,705,548.00View SEC Filing  
5/21/2013William B HayesCFOSell127,200$100.00$12,720,000.00View SEC Filing  
5/17/2013F Samuel Eberts IIIInsiderSell10,000$98.47$984,700.00View SEC Filing  
5/10/2013James T Jr. BoyleCOOSell68,908$93.82$6,464,948.56View SEC Filing  
5/8/2013Jean-Luc BelingardDirectorSell2,536$92.88$235,543.68View SEC Filing  
4/11/2013William B HayesCFOSell22,234$95.00$2,112,230.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Laboratory Corporation of America Holdings (NYSE:LH)
Latest Headlines for Laboratory Corporation of America Holdings (NYSE:LH)
Source:
DateHeadline
americanbankingnews.com logoSunTrust Banks Comments on Laboratory Corporation of America Holdings' Q3 2017 Earnings (LH)
www.americanbankingnews.com - September 20 at 6:36 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings to Post Q1 2019 Earnings of $2.60 Per Share, SunTrust Banks Forecasts (LH)
www.americanbankingnews.com - September 19 at 11:38 AM
americanbankingnews.com logoHead to Head Comparison: Laboratory Corporation of America Holdings (LH) and Its Peers
www.americanbankingnews.com - September 18 at 8:34 PM
bizjournals.com logoLabCorp amends credit facility to $1 billion
www.bizjournals.com - September 18 at 7:57 PM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Stock Rating Reaffirmed by Robert W. Baird
www.americanbankingnews.com - September 17 at 7:42 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 17 at 4:40 AM
seekingalpha.com logoLabCorp expands credit facility - Seeking Alpha
seekingalpha.com - September 15 at 8:29 PM
finance.yahoo.com logoLaboratory Corp. of America Holdings breached its 50 day moving average in a Bearish Manner : LH-US : September 14, 2017
finance.yahoo.com - September 15 at 5:42 AM
finance.yahoo.com logoLabCorp Presents Nine Studies, Including Novel Research on Improving Genetic Counseling Quality, at the National Society of Genetic Counselors Annual Conference
finance.yahoo.com - September 15 at 5:42 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) to Post Q1 2018 Earnings of $2.41 Per Share, William Blair Forecasts
www.americanbankingnews.com - September 14 at 10:31 AM
americanbankingnews.com logoQ3 2017 EPS Estimates for Laboratory Corporation of America Holdings (LH) Boosted by Jefferies Group
www.americanbankingnews.com - September 14 at 6:56 AM
americanbankingnews.com logoJefferies Group LLC Reiterates Hold Rating for Laboratory Corporation of America Holdings (LH)
www.americanbankingnews.com - September 13 at 9:52 AM
americanbankingnews.com logoFY2017 EPS Estimates for Laboratory Corporation of America Holdings Boosted by Analyst (LH)
www.americanbankingnews.com - September 13 at 8:30 AM
americanbankingnews.com logo$2.53 Billion in Sales Expected for Laboratory Corporation of America Holdings (LH) This Quarter
www.americanbankingnews.com - September 12 at 6:06 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Rating Increased to Top Pick at Canaccord Genuity
www.americanbankingnews.com - September 11 at 8:22 AM
finance.yahoo.com logoLabCorp Named Among “The World’s Most Innovative Companies” in Forbes’ 2017 Ranking
finance.yahoo.com - September 8 at 1:17 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) CEO Sells $7,009,602.82 in Stock
www.americanbankingnews.com - September 7 at 4:24 PM
americanbankingnews.com logoInsider Selling: Laboratory Corporation of America Holdings (LH) CEO Sells 132,713 Shares of Stock
www.americanbankingnews.com - September 7 at 1:26 PM
americanbankingnews.com logoValuEngine Upgrades Laboratory Corporation of America Holdings (LH) to Buy
www.americanbankingnews.com - September 6 at 11:02 PM
finance.yahoo.com logoDynacare Acquires Hooper-Holmes Canada Ltd.
finance.yahoo.com - September 6 at 9:37 PM
finance.yahoo.com logoLabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
finance.yahoo.com - September 5 at 3:57 PM
finance.yahoo.com logoLaboratory Corp. of America Holdings breached its 50 day moving average in a Bullish Manner : LH-US : September 4, 2017
finance.yahoo.com - September 4 at 7:12 PM
finance.yahoo.com logoLabCorp Completes Acquisition of Chiltern
finance.yahoo.com - September 2 at 5:12 AM
finance.yahoo.com logoThe National Football League Alumni Association, Cancer Treatment Centers of America® and LabCorp Team Up to Offer Prostate Cancer Screenings Starting in September
finance.yahoo.com - August 31 at 6:51 AM
bizjournals.com logoN.C. firms land on Forbes' list of the most innovative companies in the world
www.bizjournals.com - August 30 at 5:53 AM
americanbankingnews.com logoF Samuel Eberts III Sells 31,500 Shares of Laboratory Corporation of America Holdings (LH) Stock
www.americanbankingnews.com - August 29 at 4:14 PM
bizjournals.com logoTriad firm lands on Forbes' list of the most innovative companies in the world - Triad Business Journal
www.bizjournals.com - August 29 at 1:07 AM
finance.yahoo.com logoTriad firm lands on Forbes' list of the most innovative companies in the world
finance.yahoo.com - August 28 at 8:05 PM
finance.yahoo.com logoLabCorp gets regulatory OK for $1.2 billion takeover of Chiltern
finance.yahoo.com - August 26 at 6:47 AM
finance.yahoo.com logoLabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer
finance.yahoo.com - August 25 at 7:53 AM
finance.yahoo.com logoLaboratory Corp. of America Holdings breached its 50 day moving average in a Bearish Manner : LH-US : August 24, 2017
finance.yahoo.com - August 25 at 7:53 AM
finance.yahoo.com logoLabCorp lures BCBSNC chief medical officer
finance.yahoo.com - August 25 at 7:53 AM
finance.yahoo.com logoLabCorp creates chief medical officer position, snags BCBSNC exec
finance.yahoo.com - August 25 at 7:53 AM
finance.yahoo.com logoLabCorp’s Acquisition of Chiltern Clears Antitrust Review
finance.yahoo.com - August 25 at 7:53 AM
americanbankingnews.com logoLaboratory Corp. of America Holdings (LH) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - August 23 at 4:44 AM
americanbankingnews.com logo$2.41 Earnings Per Share Expected for Laboratory Corporation of America Holdings (LH) This Quarter
www.americanbankingnews.com - August 23 at 3:28 AM
finance.yahoo.com logoETFs with exposure to Laboratory Corp. of America Holdings : August 21, 2017
finance.yahoo.com - August 22 at 8:33 PM
nasdaq.com logoLabCorp Partners OmniSeq to Grow in Immuno-Oncology Space - Nasdaq
www.nasdaq.com - August 22 at 3:31 PM
finance.yahoo.com logoLabCorp Partners OmniSeq to Grow in Immuno-Oncology Space
finance.yahoo.com - August 22 at 3:31 PM
finance.yahoo.com logoOmniSeq and LabCorp Sign Exclusive Distribution Agreement and Series B Funding Commitment
finance.yahoo.com - August 21 at 8:24 AM
finance.yahoo.com logoLabCorp prices $1.2 billion debt offering
finance.yahoo.com - August 18 at 6:22 AM
finance.yahoo.com logoLabCorp Announces Proposed Sale of Senior Notes
finance.yahoo.com - August 16 at 5:14 AM
finance.yahoo.com logoLaboratory Corporation of America Holdings -- Moody's rates LabCorp's bond offering Baa2
finance.yahoo.com - August 16 at 5:14 AM
finance.yahoo.com logoLabCorp Prices $600,000,000 in 3.250% Senior Notes Due 2024 and $600,000,000 in 3.600% Senior Notes Due 2027
finance.yahoo.com - August 16 at 5:14 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Director Sells $486,328.00 in Stock
www.americanbankingnews.com - August 15 at 4:36 PM
americanbankingnews.com logoCritical Analysis: Laboratory Corporation of America Holdings (NYSE:LH) & Kindred Healthcare (KND)
www.americanbankingnews.com - August 13 at 2:26 AM
nasdaq.com logoSchroder Investment Management Group Buys JM Smucker Co, Laboratory Corp of America Holdings, ...
www.nasdaq.com - August 12 at 2:33 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Laboratory Corporation of America Holdings.
finance.yahoo.com - August 12 at 2:33 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Price Target Raised to $166.00 at Morgan Stanley
www.americanbankingnews.com - August 10 at 7:02 PM
finance.yahoo.com logoLaboratory Corp. of America Holdings :LH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017
finance.yahoo.com - August 10 at 2:13 AM

Social

Chart

Laboratory Corporation of America Holdings (LH) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff